← Evidence map

ArticlePloS one2026

Genomic and clinical determinants of response to Azacitidine plus venetoclax in acute myeloid leukemia: Results from the HM-SCREEN-Japan 02 study.

Tomoaki Ueda et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.

Not cited yet

Genomic and clinical determinants of response to Azacitidine plus venetoclax in acute myeloid leukemia: Results from the HM-SCREEN-Japan 02 study. | OpenQuestion